Treatment of CML-transformed B Cell Acute Lymphoblastic Leukemia (B-ALL) in Adults with Anti-CD19 Chimeric Antigen Receptor T Cell (CAR T) Therapy

Stem Cell Rev Rep. 2020 Dec;16(6):1356-1358. doi: 10.1007/s12015-020-10008-7.

¹ Department of Hematology, General Hospital of Western Threater Command, Sichuan, Chengdu, People's Republic of China. lfyh2006@yahoo.com.
² iCell Gene Therapeutics LLC, Research & Development Division, Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY, 11790, USA.
³ The Ohio State University School of Medicine, Columbus, OH, USA.
⁴ Department of Hematology, General Hospital of Western Threater Command, Sichuan, Chengdu, People's Republic of China.
⁵ Division of Hematology/Oncology MetroHealth System, Case Western Reserve University School Medicine, ‎Cleveland, OH, USA. wtse@metrohealth.org.

No abstract available

Publication types